{
  "report_rows": [
    {
      "kpi": "2Q26 adjusted diluted EPS",
      "prediction": "BEAT",
      "answer": "pred ~$2.15 vs. cons $2.11",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "2Q26 organic sales growth",
      "prediction": "BEAT",
      "answer": "pred ~4.3% vs. cons 3.6%",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "2Q26 adjusted EBITDA margin",
      "prediction": "IN-LINE",
      "answer": "pred ~26.9% vs. cons 26.8%",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY26 organic sales growth",
      "prediction": "BETTER",
      "answer": "guide ~4.0% midpoint vs. cons 3.6% (FY26)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY26 adjusted diluted EPS",
      "prediction": "BETTER",
      "answer": "guide ~$8.55 midpoint vs. cons $8.50 (FY26)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY26 adjusted EBITDA margin",
      "prediction": "UNCHANGED",
      "answer": "guide ~26.75% midpoint vs. cons 26.8% (FY26)",
      "confidence": "HIGH"
    },
    {
      "kpi": "FY26 free-cash-flow conversion",
      "prediction": "UNCHANGED",
      "answer": "guide ~100% vs. cons 100% (FY26)",
      "confidence": "HIGH"
    }
  ],
  "day1_residual_pct": 2.5,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": 3.5,
  "day5_path": "FOLLOW-THROUGH",
  "day5_rationale": "Day 1 residual ~2.5% and day 5 residual ~3.5%: an EPS/organic-growth beat paired with a ~4.0% FY26 organic-growth midpoint and ~$8.55 FY26 EPS midpoint supports modest upward revisions to the out-period earnings base rather than a one-quarter-only beat.",
  "day5_confidence": "MEDIUM"
}